Mental healthcare utilization of transgender youth before and after affirming treatment
- Hisle-Gorman, E., Schvey, N. A., Adirim, T. A., Rayne, A. K., Susi, A., Roberts, T. A., & Klein, D. A. (2021). Mental healthcare utilization of transgender youth before and after affirming treatment. The Journal of Sexual Medicine, 18(8), 1444-1454. https://doi.org/10.1016/j.jsxm.2021.05.014
- Using 8 years of retrospective medical records, this study compared the utilization of mental healthcare (e.g., mental health diagnosis, number of visits) and psychotropic medications (e.g., depression medications) across transgender and gender-diverse (TGD) military youth (i.e., whose gender identity and expression do not align with the sex assigned at birth; n = 3,754) and their cisgender siblings (i.e., whose gender aligns with the sex assigned at birth; n = 6,603). Overall, TGD youth attended more mental health visits and obtained more psychotropic medications per year than their cisgender siblings. TGD youth who initiated gender-affirming pharmaceutical treatment (e.g., hormones) during the study period also attended mental healthcare visits and used psychotropic medications at similar rates before and after treatment.
Authors
Publication Type
Focus Terms
Branch of Service
Military Affiliation
Subject Affiliation
Population
Methodology
Newsletter Date
Research summaries convey terminology used by the scientists who authored the original research article; some terminology may not align with the federal government's mandated language for certain constructs.